Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
10.94
Dollar change
+0.29
Percentage change
2.72
%
Index- P/E- EPS (ttm)-1.29 Insider Own11.29% Shs Outstand25.78M Perf Week9.40%
Market Cap282.14M Forward P/E- EPS next Y-0.28 Insider Trans2.12% Shs Float22.88M Perf Month66.77%
Income-33.20M PEG- EPS next Q-0.34 Inst Own18.37% Short Float4.67% Perf Quarter226.57%
Sales585.17M P/S0.48 EPS this Y89.76% Inst Trans-9.15% Short Ratio2.84 Perf Half Y257.52%
Book/sh9.85 P/B1.11 EPS next Y33.33% ROA-3.89% Short Interest1.07M Perf Year151.49%
Cash/sh0.85 P/C12.82 EPS next 5Y- ROE-12.41% 52W Range1.61 - 11.42 Perf YTD198.09%
Dividend Est.- P/FCF69.84 EPS past 5Y-184.24% ROI-5.01% 52W High-4.17% Beta3.16
Dividend TTM- Quick Ratio1.15 Sales past 5Y133.62% Gross Margin23.43% 52W Low579.50% ATR (14)0.88
Dividend Ex-Date- Current Ratio1.74 EPS Y/Y TTM90.33% Oper. Margin1.94% RSI (14)71.21 Volatility11.09% 11.63%
Employees1955 Debt/Eq1.69 Sales Y/Y TTM-0.18% Profit Margin-5.67% Recom1.00 Target Price15.50
Option/ShortYes / Yes LT Debt/Eq1.61 EPS Q/Q82.49% Payout- Rel Volume0.82 Prev Close10.65
Sales Surprise1.98% EPS Surprise-9.75% Sales Q/Q10.38% EarningsFeb 07 AMC Avg Volume376.53K Price10.94
SMA2023.27% SMA5074.44% SMA200151.07% Trades Volume309,450 Change2.72%
Date Action Analyst Rating Change Price Target Change
Feb-09-24Upgrade Jefferies Hold → Buy $3 → $11.50
Jul-20-23Initiated Wells Fargo Overweight $9
Jan-19-23Downgrade Jefferies Buy → Hold $10 → $8
Jan-11-23Upgrade Lake Street Hold → Buy $4 → $10
Nov-18-22Downgrade Lake Street Buy → Hold $60 → $7
Oct-04-22Initiated Jefferies Buy $27
Jan-31-22Initiated Lake Street Buy $60
Sep-20-21Initiated Craig Hallum Buy $45
Mar-25-24 09:40AM
Mar-18-24 08:50AM
Mar-12-24 04:42PM
Mar-07-24 04:20PM
12:00PM
08:50AM Loading…
08:50AM
Mar-01-24 09:40AM
Feb-29-24 08:50AM
Feb-27-24 01:34PM
Feb-20-24 07:38AM
Feb-19-24 08:50AM
Feb-14-24 09:40AM
Feb-09-24 08:25AM
Feb-08-24 09:55AM
08:54AM
06:10PM Loading…
Feb-07-24 06:10PM
04:05PM
Jan-29-24 04:05PM
Jan-27-24 09:00AM
Dec-16-23 03:01PM
Dec-15-23 08:50AM
Dec-14-23 08:14AM
Dec-12-23 07:45AM
Dec-11-23 09:54PM
04:05PM
Dec-06-23 04:30PM
Nov-27-23 04:05PM
Nov-13-23 04:05PM
Nov-08-23 07:30AM
Nov-01-23 08:00AM
08:00AM Loading…
Oct-16-23 08:00AM
Aug-29-23 06:47PM
Aug-24-23 04:05PM
Aug-15-23 03:31PM
Aug-10-23 06:15PM
04:08PM
Jul-24-23 04:35PM
Jul-20-23 08:24PM
Jun-30-23 08:44AM
Jun-05-23 09:55AM
May-30-23 08:50AM
May-25-23 08:33AM
May-19-23 08:33AM
May-18-23 09:55AM
May-13-23 08:15AM
May-11-23 05:55PM
04:05PM
May-08-23 08:18AM
06:27AM
May-04-23 08:33AM
Apr-26-23 08:33AM
Apr-11-23 09:00AM
07:27AM
Mar-24-23 08:38AM
Mar-22-23 03:45AM
Mar-15-23 07:00AM
Mar-03-23 05:30AM
Feb-27-23 06:50AM
Feb-22-23 03:23AM
Feb-14-23 04:45PM
Feb-13-23 04:05PM
Feb-06-23 10:45PM
Feb-01-23 01:15PM
Jan-23-23 04:40PM
Jan-12-23 12:29PM
Jan-10-23 04:05PM
Jan-04-23 04:30PM
Dec-15-22 08:16AM
Dec-12-22 06:55AM
Dec-08-22 04:10PM
Nov-29-22 04:55PM
Nov-28-22 04:10PM
Nov-22-22 01:01PM
Nov-01-22 08:33AM
Oct-27-22 01:09PM
Oct-26-22 07:36AM
Aug-31-22 08:33AM
Aug-25-22 11:02AM
Aug-10-22 05:00PM
04:05PM
Aug-09-22 05:09PM
Aug-01-22 04:05PM
Jul-26-22 08:33AM
Jul-25-22 09:37AM
Jul-18-22 08:33AM
Jul-14-22 08:00AM
Jul-08-22 06:24AM
Jul-07-22 04:05PM
Jun-22-22 08:33AM
Jun-15-22 12:57PM
Jun-13-22 08:10PM
Jun-09-22 05:45PM
May-16-22 11:36AM
08:53AM
May-12-22 05:18PM
May-03-22 08:04AM
Apr-26-22 04:35PM
Apr-25-22 02:00PM
Mar-17-22 03:47PM
Feb-25-22 10:33AM
Inotiv, Inc. is a pharmaceutical development company, which engages in the provision of nonclinical and analytical drug discovery and development services primarily to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to academia and government clients. It operates under the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments. The DSA segment focuses on drug discovery and development services. The RMS segment includes commercial production and selling research models, diets, bedding, and bioproducts. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Beattie John GregoryChief Operating OfficerDec 14 '23Buy3.1247,966149,836111,761Dec 15 05:33 PM
Garrett MichaelChief Commercial OfficerDec 14 '23Buy2.835,00014,14516,467Dec 15 05:33 PM